Found: 16
Select item for more details and to access through your institution.
Correction to: Co-prevalence of human Papillomaviruses (HPV) and Epstein–Barr virus (EBV) in healthy blood donors from diverse nationalities in Qatar.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
HPV and Recurrent Respiratory Papillomatosis: A Brief Review.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 11, p. 1279, doi. 10.3390/life11111279
- By:
- Publication type:
- Article
Fascin in Gynecological Cancers: An Update of the Literature.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5760, doi. 10.3390/cancers13225760
- By:
- Publication type:
- Article
Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 5, p. 646, doi. 10.3390/cancers11050646
- By:
- Publication type:
- Article
Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 363, doi. 10.3390/cancers11030363
- By:
- Publication type:
- Article
Co-presence of human papillomaviruses and Epstein–Barr virus is linked with advanced tumor stage: a tissue microarray study in head and neck cancer patients.
- Published in:
- Cancer Cell International, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12935-020-01348-y
- By:
- Publication type:
- Article
Effects of neratinib on angiogenesis and the early stage of the embryo using chicken embryo as a model.
- Published in:
- Biomolecules & Biomedicine, 2024, v. 24, n. 3, p. 575, doi. 10.17305/bb.2023.9869
- By:
- Publication type:
- Article
Advances in nanotechnology-enabled drug delivery for combining PARP inhibitors and immunotherapy in advanced ovarian cancer.
- Published in:
- Biomolecules & Biomedicine, 2024, v. 24, n. 2, p. 230, doi. 10.17305/bb.2023.9757
- By:
- Publication type:
- Article
Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells via Erk1/Erk2 and β-Catenin Signaling Pathways.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.630408
- By:
- Publication type:
- Article
Coinfection of HPVs Is Associated with Advanced Stage in Colorectal Cancer Patients from Qatar.
- Published in:
- Pathogens, 2023, v. 12, n. 3, p. 424, doi. 10.3390/pathogens12030424
- By:
- Publication type:
- Article
High-Risk Human Papillomaviruses and Epstein–Barr Virus in Colorectal Cancer and Their Association with Clinicopathological Status.
- Published in:
- Pathogens, 2020, v. 9, n. 6, p. 452, doi. 10.3390/pathogens9060452
- By:
- Publication type:
- Article
Co-Incidence of Epstein–Barr Virus and High-Risk Human Papillomaviruses in Cervical Cancer of Syrian Women.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00250
- By:
- Publication type:
- Article
Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Incidence of HPVs, EBV, and MMTV-Like Virus in Breast Cancer in Qatar.
- Published in:
- Intervirology, 2022, v. 65, n. 4, p. 188, doi. 10.1159/000525277
- By:
- Publication type:
- Article
Co-incidence of Human Papillomaviruses and Epstein–Barr Virus Is Associated With High to Intermediate Tumor Grade in Human Head and Neck Cancer in Syria.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01016
- By:
- Publication type:
- Article
Co-prevalence of human Papillomaviruses (HPV) and Epstein–Barr virus (EBV) in healthy blood donors from diverse nationalities in Qatar.
- Published in:
- Cancer Cell International, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12935-020-01190-2
- By:
- Publication type:
- Article